Selleck Chemicals - Model A2601 -Amivantamab (Anti-HGFR / c-Met)

Amivantamab (Anti-HGFR/c-Met) is an antibody targeting hepatocyte growth factor receptor (HGFR, also known as c-Met) with immunohistochemical activity against non-small cell lung cancer (NSCLC). MW: 145.88KD.